Clinical Trials Browser

Phase 1/2 × Unknown × MART-1 Antigen × Clear all

NCT00010309 2014-01-06

Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

Phase 1/2 Unknown

Melanoma